Genetic diseases mimicking multiple sclerosis

References

• Tarlinton RE, Khaibullin T, Granatov E, et al. The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis. Int J Mol Sci. 2019;20(2):303. [published Online First: 2019/01/17]
   PubMed Web of Science ®Google Scholar
• Tarlinton RE, Martynova E, Rizvanov AA, et al. Role of viruses in the pathogenesis of multiple sclerosis. Viruses. 2020;12(6):643. [published Online First: 2020/06/18]
   Web of Science ®Google Scholar
• Didonna A, Oksenberg JR. The genetics of multiple sclerosis. In: Zagon IS, McLaughlin PJ, editors Multiple sclerosis: perspectives in treatment and pathogenesis. Brisbane (AU): Codon Publications; 2017 Nov 27. Chapter 1.
   Google Scholar
• Maghzi A-H, Borazanci A, McGee J, et al. Multiple sclerosis: pathophysiology, clinical features, diagnosis, and management. Neuroinflammation. 2011;1–23.
   PubMed Web of Science ®Google Scholar
• Gelfand JM. Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. Handb Clin Neurol. 2014;122:269–290. [published Online First: 2014/02/11].
   PubMedGoogle Scholar
• Abou Zeid N, Bhatti MT. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations. Neurologist. 2008;14(4):207–223. [published Online First: 2008/07/12].
   PubMed Web of Science ®Google Scholar
• Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273–1280. [published Online First: 2006/03/24].
   PubMed Web of Science ®Google Scholar
• De Ridder D, Van Der Aa F, Debruyne J, et al. Consensus guidelines on the neurologist’s role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis. Clin Neurol Neurosurg. 2013;115(10):2033–2040. [published Online First: 2013/07/25]
   PubMed Web of Science ®Google Scholar
• Preziosi G, Gordon-Dixon A, Emmanuel A. Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degener Neurol Neuromuscul Dis. 2018;8:79–90. [published Online First: 2018/12/26].
   PubMed Web of Science ®Google Scholar
• Bitirgen G, Akpinar Z, Malik RA, et al. Use of corneal confocal microscopy to detect corneal nerve loss and increased dendritic cells in patients with multiple sclerosis. JAMA Ophthalmol. 2017;135(7):777–782. [published Online First: 2017/06/02]
   PubMed Web of Science ®Google Scholar
• Petropoulos IN, Kamran S, Li Y, et al. Corneal confocal microscopy: an imaging endpoint for axonal degeneration in multiple sclerosis. Invest Ophthalmol Vis Sci. 2017;58(9):3677–3681. [published Online First: 2017/07/21]
   PubMed Web of Science ®Google Scholar
• Mikolajczak J, Zimmermann H, Kheirkhah A, et al. Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density. Mult Scler. 2017;23(14):1847–1853. [published Online First: 2016/11/05]
   PubMed Web of Science ®Google Scholar
• Jamali A, Sadeghi-Demneh E, Fereshtenajad N, et al. Somatosensory impairment and its association with balance limitation in people with multiple sclerosis. Gait Posture. 2017;57:224–229. [published Online First: 2017/07/02]
   PubMed Web of Science ®Google Scholar
• Truini A, Galeotti F, La Cesa S, et al. Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study. Pain. 2012;153(10):2048–2054. [published Online First: 2012/07/14]
   PubMed Web of Science ®Google Scholar
• Crnosija L, Adamec I, Lovric M, et al. Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis. Clin Neurophysiol. 2016;127(1):864–869. [published Online First: 2015/07/04]
   PubMed Web of Science ®Google Scholar
• Pinter A, Cseh D, Sarkozi A, et al. Autonomic dysregulation in multiple sclerosis. Int J Mol Sci. 2015;16(8):16920–16952. [published Online First: 2015/07/28]
   PubMed Web of Science ®Google Scholar
• Saari A, Tolonen U, Paakko E, et al. Sympathetic skin responses in multiple sclerosis. Acta Neurol Scand. 2008;118(4):226–231. [published Online First: 2008/03/22]
   PubMed Web of Science ®Google Scholar
• Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med. 2012;103(2):73–96. [published Online First: 2012/04/20].
   PubMed Web of Science ®Google Scholar
• Luczynski P, Laule C, Hsiung GR, et al. Coexistence of multiple sclerosis and Alzheimer’s disease: a review. Mult Scler Relat Disord. 2019;27:232–238. [published Online First: 2018/11/12]
   PubMed Web of Science ®Google Scholar
• Defer G, Branger P Dementia in multiple sclerosis. In book: Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases, 2015:257–269.
   Google Scholar
• Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS Drugs. 2018;32(2):117–133. [published Online First: 2018/02/09].
   PubMed Web of Science ®Google Scholar
• Kosmidis MH, Giannakou M, Messinis L, et al. Psychotic features associated with multiple sclerosis. Int Rev Psychiatry. 2010;22(1):55–66. [published Online First: 2010/03/18]
   PubMed Web of Science ®Google Scholar
• Bustuchina Vlaicu M. Epilepsy in multiple sclerosis as a network disease. Mult Scler Relat Disord. 2019;36:101390. [published Online First: 2019/09/24].
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. [published Online First: 2017/12/26]
   PubMed Web of Science ®Google Scholar
• Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858–1875. [published Online First: 2019/06/19]
   PubMed Web of Science ®Google Scholar
• Deisenhammer F, Zetterberg H, Fitzner B, et al. The cerebrospinal fluid in multiple sclerosis. Front Immunol. 2019;10(726). DOI:10.3389/fimmu.2019.00726
   PubMed Web of Science ®Google Scholar
• Gramsch C, Nensa F, Kastrup O, et al. Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis. Acta Radiol. 2015;56(5):622–627. [published Online First: 2014/05/29]
   PubMed Web of Science ®Google Scholar
• Hu XY, Rajendran L, Lapointe E, et al. Three-dimensional MRI sequences in MS diagnosis and research. Mult Scler. 2019;25(13):1700–1709. [published Online First: 2019/05/23]
   PubMed Web of Science ®Google Scholar
• Lecler A, El Sanharawi I, El Methni J, et al. Improving detection of multiple sclerosis lesions in the posterior fossa using an optimized 3D-FLAIR sequence at 3T. AJNR Am J Neuroradiol. 2019;40(7):1170–1176. [published Online First: 2019/06/30]
   PubMed Web of Science ®Google Scholar
• Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain. 2002;125(Pt 10):2342–2352. [published Online First: 2002/09/24]
   PubMed Web of Science ®Google Scholar
• Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain. 2003;126(Pt 8):1734–1744. [published Online First: 2003/06/14]
   PubMed Web of Science ®Google Scholar
• Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology. 2006;66(5):685–692. [published Online First: 2006/03/15]
   PubMed Web of Science ®Google Scholar
• Faizy TD, Thaler C, Ceyrowski T, et al. Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period. PLoS One. 2017;12(2):e0172923. [published Online First: 2017/02/25]
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236(1):254–260. [published Online First: 2005/07/01]
   PubMed Web of Science ®Google Scholar
• Simon B, Schmidt S, Lukas C, et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol. 2010;20(7):1675–1683. [published Online First: 2010/01/23]
   PubMed Web of Science ®Google Scholar
• Kaisey M, Solomon AJ, Luu M, et al. Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Mult Scler Relat Disord. 2019;30:51–56. [published Online First: 2019/02/10]
   PubMed Web of Science ®Google Scholar
• Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol. 2009;8(4):643–653. [published Online First: 2009/06/23]
   PubMed Web of Science ®Google Scholar
• Locatelli M, Padovani A, Pezzini A. Pathophysiological mechanisms and potential therapeutic targets in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Front Pharmacol. 2020;11:321. [published Online First: 2020/04/02].
   PubMed Web of Science ®Google Scholar
• Guey S, Mawet J, Herve D, et al. Prevalence and characteristics of migraine in CADASIL. Cephalalgia. 2016;36(11):1038–1047. [published Online First: 2015/12/10]
   PubMed Web of Science ®Google Scholar
• Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346(8980):934–939. [published Online First: 1995/10/07]
   PubMed Web of Science ®Google Scholar
• Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44(5):731–739. [published Online First: 1998/11/18]
   PubMed Web of Science ®Google Scholar
• Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127(Pt 11):2533–2539. [published Online First: 2004/09/15]
   PubMed Web of Science ®Google Scholar
• Gunda B, Herve D, Godin O, et al. Effects of gender on the phenotype of CADASIL. Stroke. 2012;43(1):137–141. [published Online First: 2011/10/29]
   PubMed Web of Science ®Google Scholar
• Vahedi K, Chabriat H, Levy C, et al. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 2004;61(8):1237–1240. [published Online First: 2004/08/18]
   PubMedGoogle Scholar
• Herve D, Chabriat H. Cadasil. J Geriatr Psychiatry Neurol. 2010;23(4):269–76. [published Online First: 2010/11/04].
   PubMed Web of Science ®Google Scholar
• Viswanathan A, Gschwendtner A, Guichard JP, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology. 2007;69(2):172–179. [published Online First: 2007/07/11]
   PubMed Web of Science ®Google Scholar
• Buffon F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77(2):175–180. [published Online First: 2006/01/20]
   PubMed Web of Science ®Google Scholar
• Valenti R, Pescini F, Antonini S, et al. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview. Acta Neurol Scand. 2011;124(6):390–395. [published Online First: 2011/03/25]
   PubMed Web of Science ®Google Scholar
• Park S, Park B, Koh MK, et al. Case report: bipolar disorder as the first manifestation of CADASIL. BMC Psychiatry. 2014;14:175. [published Online First: 2014/06/16]
   PubMed Web of Science ®Google Scholar
• Carone DA. CADASIL and multiple sclerosis: a case report of prolonged misdiagnosis. Appl Neuropsychol Adult. 2017;24(3):294–297. [published Online First: 2016/10/08].
   PubMed Web of Science ®Google Scholar
• Khan A, Abedi V, Li J, et al. CADASIL vs. multiple sclerosis: is it misdiagnosis or concomitant? A case series. Front Neurol. 2020;11:860. [published Online First: 2020/10/06]
   PubMed Web of Science ®Google Scholar
• Joshi S, Yau W, Kermode A. CADASIL mimicking multiple sclerosis: the importance of clinical and MRI red flags. J Clin Neurosci. 2017;35:75–77. [published Online First: 2016/10/25].
   PubMed Web of Science ®Google Scholar
• Schiess N, Huether K, Szolics M, et al. Multiple sclerosis or “inflammatory CADASIL?”: case report and review of the literature. Clin Neurol Neurosurg. 2018;173:196–199. [published Online First: 2018/02/17]
   PubMed Web of Science ®Google Scholar
• Bouley AJ, Yaghi S. CADASIL as a multiple sclerosis mimic. R I Med J. [2013] 2017;100(11):37–38. [published Online First: 2017/11/01].
   Google Scholar
• Saleem S, Anwar A, Abbasi Z, et al. Periventricular hyperintensities mimicking multiple sclerosis. Cureus. 2019;11(8):e5326. [published Online First: 2019/10/11]
   PubMed Web of Science ®Google Scholar
• Motolese F, Rossi M, Gangemi E, et al. CADASIL as multiple sclerosis Mimic: a 48-year-old man with severe leukoencephalopathy and spinal cord involvement. Mult Scler Relat Disord. 2020;41:102014. [published Online First: 2020/03/03]
   PubMed Web of Science ®Google Scholar
• O’Riordan S, Nor AM, Hutchinson M. CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler. 2002;8(5):430–432. [published Online First: 2002/10/03].
   PubMed Web of Science ®Google Scholar
• Phillips CD, Zuckerman SJ, Medical Education C. CADASIL can mimic multiple sclerosis. J La State Med Soc. 2010;162(3):174. [published Online First: 2010/07/30].
   PubMedGoogle Scholar
• Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51(2):452–457. [published Online First: 1998/08/26]
   PubMed Web of Science ®Google Scholar
• O’Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56(5):628–634. [published Online First: 2001/03/14]
   PubMed Web of Science ®Google Scholar
• Van Den Boom R, Lesnik Oberstein SA, Ferrari MD, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages--3rd-6th decades. Radiology. 2003;229(3):683–690. [published Online First: 2003/11/01]
   PubMed Web of Science ®Google Scholar
• Lee JS, Kang CH, Park SQ, et al. Clinical significance of cerebral microbleeds locations in CADASIL with R544C NOTCH3 mutation. PLoS One. 2015;10(2):e0118163. [published Online First: 2015/02/19]
   PubMed Web of Science ®Google Scholar
• Geraldes R, Ciccarelli O, Barkhof F, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018;14(4):199–213. [published Online First: 2018/03/10]
   PubMed Web of Science ®Google Scholar
• Gravesteijn G, Munting LP, Overzier M, et al. Progression and classification of granular osmiophilic material (GOM) deposits in functionally characterized human NOTCH3 transgenic mice. Transl Stroke Res. 2020;11(3):517–527. [published Online First: 2019/11/02]
   PubMed Web of Science ®Google Scholar
• Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis. 2011;20(2):85–93. [published Online First: 2011/01/11].
   PubMed Web of Science ®Google Scholar
• Nozaki H, Nishizawa M, Onodera O. Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2014;45(11):3447–3453. [published Online First: 2014/08/15].
   PubMed Web of Science ®Google Scholar
• Hara K, Shiga A, Fukutake T, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009;360(17):1729–1739. [published Online First: 2009/04/24]
   PubMed Web of Science ®Google Scholar
• Yu Z, Cao S, Wu A, et al. Genetically confirmed CARASIL: case report with novel HTRA1 mutation and literature review. World Neurosurg. 2020;143:121–128. [published Online First: 2020/05/24]
   PubMed Web of Science ®Google Scholar
• Sondergaard CB, Nielsen JE, Hansen CK, et al. Hereditary cerebral small vessel disease and stroke. Clin Neurol Neurosurg. 2017;155:45–57. [published Online First: 2017/03/04]
   PubMed Web of Science ®Google Scholar
• Tikka S, Baumann M, Siitonen M, et al. CADASIL and CARASIL. Brain Pathol. 2014;24(5):525–544. [published Online First: 2014/10/18]
   PubMed Web of Science ®Google Scholar
• Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencepahlopathy (CARASIL) presenting with cerebral small-vessel disease, alopecia and spinal degeneration. Neurol Med. 2010;72:391–399.
   Google Scholar
• Nozaki H, Sekine Y, Fukutake T, et al. Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology. 2015;85(5):459–463. [published Online First: 2015/07/04]
   PubMed Web of Science ®Google Scholar
• Graziano AC, Cardile V. History, genetic, and recent advances on Krabbe disease. Gene. 2015;555(1):2–13. [published Online First: 2014/09/28].
   PubMed Web of Science ®Google Scholar
• Pavuluri P, Vadakedath S, Gundu R, et al. Krabbe disease: report of a rare lipid storage and neurodegenerative disorder. Cureus. 2017;9(1):e949. [published Online First: 2017/02/09]
   PubMed Web of Science ®Google Scholar
• Tomas J, Duraes J, Lacerda L, et al. Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation. BMJ Case Rep. 2015;2015. DOI:10.1136/bcr-2015-210625. [published Online First: 2015/09/24].
   Google Scholar
• Wenger DA, Luzi P. Chapter 34 - Krabbe disease: globoid cell leukodystrophy. In: Rosenberg RN, Pascual JM, editors. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease. Sixth ed. Academic Press; 2020. p. 481–491.
   Google Scholar
• Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752–759. [published Online First: 2018/10/10].
   PubMed Web of Science ®Google Scholar
• Rizzo MA, Hadjimichael OC, Preiningerova J, et al. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10(5):589–595. [published Online First: 2004/10/09]
   PubMed Web of Science ®Google Scholar
• Oreja-Guevara C, Gonzalez-Segura D, Vila C. Spasticity in multiple sclerosis: results of a patient survey. Int J Neurosci. 2013;123(6):400–408. [published Online First: 2013/01/10].
   PubMed Web of Science ®Google Scholar
• Debs R, Froissart R, Aubourg P, et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis. 2013;36(5):859–868. [published Online First: 2012/12/01]
   PubMed Web of Science ®Google Scholar
• Zhang T, Yan C, Ji K, et al. Adult-onset Krabbe disease in two generations of a Chinese family. Ann Transl Med. 2018;6(10):174. [published Online First: 2018/06/29]
   PubMed Web of Science ®Google Scholar
• Durães J, Salsano E, Macário M. Adult-onset Krabbe disease: the importance of a systematic approach to brain MRI findings. Neurol Clin Pract. 2021;11(1):e15.
   PubMedGoogle Scholar
• Bajaj NP, Waldman A, Orrell R, et al. Familial adult onset of Krabbe’s disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry. 2002;72(5):635–638. [published Online First: 2002/04/24]
   PubMed Web of Science ®Google Scholar
• Muthusamy K, Sudhakar SV, Thomas M, et al. Revisiting magnetic resonance imaging pattern of Krabbe disease - Lessons from an Indian cohort. J Clin Imaging Sci. 2019;9:25. [published Online First: 2019/08/27]
   PubMed Web of Science ®Google Scholar
• Adachi H, Ishihara K, Tachibana H, et al. Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy. Muscle Nerve. 2016;54(1):152–157. [published Online First: 2016/02/04]
   PubMed Web of Science ®Google Scholar
• Cousyn L, Law-Ye B, Pyatigorskaya N, et al. Brain MRI features and scoring of leukodystrophy in adult-onset Krabbe disease. Neurology. 2019;93(7):e647–e52. [published Online First: 2019/07/25]
   PubMed Web of Science ®Google Scholar
• Wu GF, Schwartz ED, Lei T, et al. Relation of vision to global and regional brain MRI in multiple sclerosis. N eurology. 2007;69(23):2128–2135. [publis hed Onli ne First: 20 07/09 /21]
   PubMed Web of Science ®Google Scholar
• Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye Brain. 2016;8:195–202. [published Online First: 2017/05/26].
   PubMed Web of Science ®Google Scholar
• Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14(10):486. [published Online First: 2014/08/15].
   PubMed Web of Science ®Google Scholar
• Kemper AR, Brosco J, Comeau AM, et al. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med. 2017;19(1):121–126. [published Online First: 2016/06/24]
   PubMed Web of Science ®Google Scholar
• Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7(1):51. [published Online First: 2012/08/15]
   PubMed Web of Science ®Google Scholar
• van Geel BM, Bezman L, Loes DJ, et al. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001;49(2):186–194. [published Online First: 2001/02/28]
   PubMed Web of Science ®Google Scholar
• De Beer M, Engelen M, van Geel BM. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy. Neurology. 2014;83(24):2227–2231. [published Online First: 2014/11/08].
   PubMed Web of Science ®Google Scholar
• Jangouk P, Zackowski KM, Naidu S, et al. Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated. Mol Genet Metab. 2012;105(2):180–185. [published Online First: 2011/11/25]
   PubMed Web of Science ®Google Scholar
• Berger J, Gartner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta. 2006;1763(12):1721–1732. [published Online First: 2006/09/05].
   PubMed Web of Science ®Google Scholar
• Di Filippo M, Luchetti E, Prontera P, et al. Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis. J Neurol. 2011;258(2):323–324. [published Online First: 2010/08/31]
   PubMed Web of Science ®Google Scholar
• Fatemi A, Barker PB, Ulug AM, et al. MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology. 2003;60(8):1301–1307. [published Online First: 2003/04/23]
   PubMed Web of Science ®Google Scholar
• Van der Knaap MS, Valk J. X-linked adrenoleukodystrophy.In:magnetic resonance of myelination and myelin disorders. Springer-Verlag Berlin Heidelberg. 2005;176–190.
   Google Scholar
• Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003;61(3):369–374. [published Online First: 2003/08/13]
   PubMed Web of Science ®Google Scholar
• Brandao de Paiva AR, Pucci Filho CR, Porto AM, et al. When multiple sclerosis and X-linked adrenoleukodystrophy are tangled: a challenging case. Neurol Clin Pract. 2018;8(2):156–158. [published Online First: 2018/05/01]
   PubMedGoogle Scholar
• Jenkins T, Sarasamma P, Gillett G, et al. Multiple sclerosis in an adrenoleukodystrophy carrier. Clin Pract. 2011;1(4):e125. [published Online First: 2011/09/28]
   PubMedGoogle Scholar
• Burtman E, Regelmann MO. Endocrine Dysfunction in X-Linked Adrenoleukodystrophy. Endocrinol Metab Clin North Am. 2016;45(2):295–309. [published Online First: 2016/06/01].
   PubMed Web of Science ®Google Scholar
• Cairns T, Muntze J, Gernert J, et al. Hot topics in Fabry disease. Postgrad Med J. 2018;94(1118):709–713. [published Online First: 2018/12/19]
   PubMed Web of Science ®Google Scholar
• Zarate YA, Hopkin RJ. Fabry’s disease. Lancet. 2008;372(9647):1427–1435. [published Online First: 2008/10/23].
   PubMed Web of Science ®Google Scholar
• Michaud M, Mauhin W, Belmatoug N, et al. When and how to diagnose Fabry disease in clinical pratice. Am J Med Sci. 2020;360(6):641–649. [published Online First: 2020/07/30]
   PubMed Web of Science ®Google Scholar
• Patel MR, Cecchi F, Cizmarik M, et al. Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol. 2011;57(9):1093–1099. [published Online First: 2011/02/26]
   PubMed Web of Science ®Google Scholar
• van der Tol L, Sminia ML, Hollak CE, et al. Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review. Br J Ophthalmol. 2016;100(1):3–8. [published Online First: 2015/02/14]
   PubMed Web of Science ®Google Scholar
• Bottcher T, Rolfs A, Tanislav C, et al. Fabry disease - underestimated in the differential diagnosis of multiple sclerosis? PLoS One. 2013;8(8):e71894. [published Online First: 2013/09/10]
   PubMed Web of Science ®Google Scholar
• Shribman SE, Shah AR, Werring DJ, et al. Fabry disease mimicking multiple sclerosis: lessons from two case reports. Mult Scler Relat Disord. 2015;4(2):170–175. [published Online First: 2015/03/20]
   PubMed Web of Science ®Google Scholar
• Lidove O, Kaminsky P, Hachulla E, et al. Fabry disease ‘the new great imposter’: results of the french observatoire in internal medicine departments (FIMeD). Clin Genet. 2012;81(6):571–577. [published Online First: 2011/06/01]
   PubMed Web of Science ®Google Scholar
• Saip S, Uluduz D, Erkol G. Fabry disease mimicking multiple sclerosis. Clin Neurol Neurosurg. 2007;109(4):361–363. [published Online First: 2007/01/20].
   PubMed Web of Science ®Google Scholar
• Callegaro D, Kaimen-Maciel DR. Fabry’s disease as a differential diagnosis of MS. Int MS J. 2006;13(1):27–30. [published Online First: 2006/01/20].
   PubMedGoogle Scholar
• Invernizzi P, Bonometti MA, Turri E, et al. A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? Mult Scler. 2008;14(7):1003–1006. [published Online First: 2008/07/18]
   PubMed Web of Science ®Google Scholar
• De Cobelli F, Esposito A, Belloni E, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol. 2009;192(3):W97–102. [published Online First: 2009/02/24]
   PubMed Web of Science ®Google Scholar
• Rost NS, Cloonan L, Kanakis AS, et al. Determinants of white matter hyperintensity burden in patients with Fabry disease. Neurology. 2016;86(20):1880–1886. [published Online First: 2016/05/11]
   PubMed Web of Science ®Google Scholar
• Li R, Messing A, Goldman JE, et al. GFAP mutations in Alexander disease. Int J Dev Neurosci. 2002;20(3–5):259–268. [published Online First: 2002/08/15]
   PubMed Web of Science ®Google Scholar
• Messing A. Alexander disease. Handb Clin Neurol. 2018;148:693–700. [published Online First: 2018/02/27].
   PubMedGoogle Scholar
• Ahmad O, Rowe DB. Adult-onset Alexander’s disease mimicking degenerative disease. Pract Neurol. 2015;15(5):393–395. [published Online First: 2015/05/30].
   PubMedGoogle Scholar
• Stumpf E, Masson H, Duquette A, et al. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Arch Neurol. 2003;60(9):1307–1312. [published Online First: 2003/09/17]
   PubMedGoogle Scholar
• Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain. 2008;131(Pt 9):2321–2331. [published Online First: 2008/08/08]
   PubMed Web of Science ®Google Scholar
• Howard KL, Hall DA, Moon M, et al. Adult-onset Alexander disease with progressive ataxia and palatal tremor. Mov Disord. 2008;23(1):118–122. [published Online First: 2007/10/27]
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Shaw CE, Jarosz J, et al. Alexander disease with hypothermia, microcoria, and psychiatric and endocrine disturbances. Neurology. 2007;68(16):1322–1323. [published Online First: 2007/04/18]
   PubMed Web of Science ®Google Scholar
• Romano S, Salvetti M, Ceccherini I, et al. Brainstem signs with progressing atrophy of medulla oblongata and upper cervical spinal cord. Lancet Neurol. 2007;6(6):562–570. [published Online First: 2007/05/19]
   PubMed Web of Science ®Google Scholar
• Brockmann K, Meins M, Taubert A, et al. A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease? Eur Neurol. 2003;50(2):100–105. [published Online First: 2003/08/29]
   PubMed Web of Science ®Google Scholar
• Dooves S, Bugiani M, Postma NL, et al. Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Invest. 2016;126(4):1512–1524. [published Online First: 2016/03/15]
   PubMed Web of Science ®Google Scholar
• Cai MT, Zhang YX, Zheng Y, et al. Brain lesion distribution criteria distinguish demyelinating diseases in China. Ann Clin Transl Neurol. 2019;6(10):2048–2053. [published Online First: 2019/10/01]
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Leegwater PA, Konst AA, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol. 2002;51(2):264–270. [published Online First: 2002/02/09]
   PubMed Web of Science ®Google Scholar
• Cabilly Y, Barbi M, Geva M, et al. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease. PLoS One. 2012;7(10):e46715. [published Online First: 2012/10/12]
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Leegwater PA, van Berkel CG, et al. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults. Neurology. 2004;62(9):1598–1600. [published Online First: 2004/05/12]
   PubMed Web of Science ®Google Scholar
• Ayrignac X, Menjot de Champfleur N, Menjot de Champfleur S, et al. Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease. Eur J Neurol. 2016;23(6):995–1000. [published Online First: 2016/01/05]
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5(5):413–423. [published Online First: 2006/04/25].
   PubMed Web of Science ®Google Scholar
• Herwerth M, Schwaiger BJ, Kreiser K, et al. Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: a case report. Mult Scler. 2015;21(5):666–668. [published Online First: 2014/08/20]
   PubMed Web of Science ®Google Scholar
• Ho CS, Mangelsdorf S, Walterfang M. The disappearance of white matter in an adult-onset disease: a case report. BMC Psychiatry. 2020;20(1):137. [published Online First: 2020/03/30].
   PubMed Web of Science ®Google Scholar
• Renard D, Brochet B, Vukusic S, et al. Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions. Eur Neurol. 2012;68(3):156–161. [published Online First: 2012/08/22]
   PubMed Web of Science ®Google Scholar
• Natarajan R, Hagman S, Wu X, et al. Diffusion tensor imaging in NAWM and NADGM in MS and CIS: association with candidate biomarkers in Sera. Mult Scler Int. 2013;2013:265259. [published Online First: 2014/01/24]
   PubMedGoogle Scholar
• Ohtake H, Shimohata T, Terajima K, et al. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology. 2004;62(9):1601–1603. [published Online First: 2004/05/12]
   PubMed Web of Science ®Google Scholar
• Denier C, Orgibet A, Roffi F, et al. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis. Neurology. 2007;68(18):1538–1539. [published Online First: 2007/05/02]
   PubMed Web of Science ®Google Scholar
• Labauge P, Horzinski L, Ayrignac X, et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain. 2009;132(Pt 8):2161–2169. [published Online First: 2009/07/25]
   PubMed Web of Science ®Google Scholar
• Wei C, Qin Q, Chen F, et al. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia. BMC Neurol. 2019;19(1):203. [published Online First: 2019/08/24]
   PubMed Web of Science ®Google Scholar
• Patil SA, Maegawa GH. Developing therapeutic approaches for metachromatic leukodystrophy. Drug Des Devel Ther. 2013;7:729–745. [published Online First: 2013/08/24].
   PubMed Web of Science ®Google Scholar
• Sevin C, Aubourg P, Cartier N. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis. 2007;30(2):175–183. [published Online First: 2007/03/10].
   PubMed Web of Science ®Google Scholar
• Beerepoot S, Nierkens S, Boelens JJ, et al. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet J Rare Dis. 2019;14(1):240. [published Online First: 2019/11/07]
   PubMed Web of Science ®Google Scholar
• Shaimardanova AA, Chulpanova DS, Solovyeva VV, et al. Metachromatic leukodystrophy: diagnosis, modeling, and treatment approaches. Front Med (Lausanne). 2020;7:576221. [published Online First: 2020/11/17]
   PubMed Web of Science ®Google Scholar
• Agarwal A, Shipman PJ. Gallbladder polyposis in metachromatic leukodystrophy. Pediatr Radiol. 2013;43(5):631–633. [published Online First: 2012/10/12].
   PubMed Web of Science ®Google Scholar
• Martin A, Sevin C, Lazarus C, et al. Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution. AJNR Am J Neuroradiol. 2012;33(9):1731–1739. [published Online First: 2012/04/28]
   PubMed Web of Science ®Google Scholar
• Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72(8):750–759. [published Online First: 2009/02/25].
   PubMed Web of Science ®Google Scholar
• Chebel S, Barboura I, Boughammoura-Bouatay A, et al. Adult-type metachromatic leukodystrophy mimicking multiple sclerosis. Can J Neurol Sci. 2009;36(4):521–523. [published Online First: 2009/08/05]
   PubMed Web of Science ®Google Scholar
• Kazibutowska Z, Bal A, Golba A, et al. Metachromatic leukodystrophy in adult patient initially diagnosed as multiple sclerosis. Neurol Neurochir Pol. 2002;36(6):1209–1219. [published Online First: 2003/04/29]
   PubMedGoogle Scholar
• Zarei M, Chandran S, Compston A, et al. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872–877. [published Online First: 2003/06/18]
   PubMed Web of Science ®Google Scholar
• Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49(3):157–163. [published Online First: 2004/04/23].
   PubMed Web of Science ®Google Scholar
• Deloire MS, Salort E, Bonnet M, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(4):519–526. [published Online First: 2005/03/19]
   PubMed Web of Science ®Google Scholar
• van Rappard DF, De Vries ALC, Oostrom KJ, et al. Slowly progressive psychiatric symptoms: think metachromatic leukodystrophy. J Am Acad Child Adolesc Psychiatry. 2018;57(2):74–76. [published Online First: 2018/02/08]
   PubMed Web of Science ®Google Scholar
• Nagappa M, Bindu PS, Chiplunkar S, et al. Child neurology: Sjogren-Larsson syndrome. Neurology. 2017;88(1):e1–e4. [published Online First: 2016/12/28]
   PubMed Web of Science ®Google Scholar
• Bindu PS. Sjogren-Larsson syndrome: mechanisms and management. Appl Clin Genet. 2020;13:13–24. [published Online First: 2020/02/06].
   PubMed Web of Science ®Google Scholar
• Nikkhah K, Ghabeli-Juibary A, Zamanian S. White matter diseases YES, multiple sclerosis NO, Sjogren - Larsson syndrome: another differential diagnosis of multiple sclerosis. Caspian J Neurol Sci. 2015;1(3):47–51.
   Google Scholar
• Dutra LA, Braga-Neto P, Pedroso JL, et al. Sjogren-Larsson syndrome. Adv Exp Med Biol. 2012;724:344–350. [published Online First: 2012/03/14]
   PubMed Web of Science ®Google Scholar
• Staps P, Cruysberg JRM, Roeleveld N, et al. Retinal morphology in Sjögren-Larsson syndrome on OCT: from metabolic crystalline maculopathy to early-onset macular degeneration. Ophthalmol Retina. 2019;3(6):500–509.
   PubMedGoogle Scholar
• Fouzdar-Jain S, Suh DW, Rizzo WB. Sjogren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype. Ophthalmic Genet. 2019;40(4):298–308. [published Online First: 2019/09/13].
   PubMed Web of Science ®Google Scholar
• Fuijkschot J, Theelen T, Seyger MM, et al. Sjogren-Larsson syndrome in clinical practice. J Inherit Metab Dis. 2012;35(6):955–962. [published Online First: 2012/07/27]
   PubMed Web of Science ®Google Scholar
• Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2011;44(2):200–205. [published Online First: 2011/12/27]
   PubMed Web of Science ®Google Scholar
• Shu Y, Long L, Liao S, et al. Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids. BMC Neurol. 2016;16(1):171. [published Online First: 2016/09/14]
   PubMed Web of Science ®Google Scholar
• Saitoh BY, Yamasaki R, Hiwatashi A, et al. Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: a preliminary cross-sectional study. Mult Scler Relat Disord. 2019;31:22–31. [published Online First: 2019/03/23]
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Kondo Y, Yoshida K, et al. Corpus callosum atrophy in patients with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: an MRI-based study. Intern Med. 2014;53(1):21–27. [published Online First: 2014/01/07]
   PubMed Web of Science ®Google Scholar
• Granberg T, Hashim F, Andersen O, et al. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls. Eur J Neurol. 2016;23(4):817–822. [published Online First: 2016/01/13]
   PubMed Web of Science ®Google Scholar
• Trip SA, Miller DH. Imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 3):iii11–iii18. [published Online First: 2005/08/19].
   PubMed Web of Science ®Google Scholar
• Lake NJ, Compton AG, Rahman S, et al. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79(2):190–203. [published Online First: 2015/10/28]
   PubMed Web of Science ®Google Scholar
• Wick R, Scott G, Byard RW. Mechanisms of unexpected death and autopsy findings in Leigh syndrome (subacute necrotising encephalomyelopathy). J Forensic Leg Med. 2007;14(1):42–45. [published Online First: 2006/02/21].
   PubMedGoogle Scholar
• Malojcic B, Brinar V, Poser C, et al. An adult case of Leigh disease. Clin Neurol Neurosurg. 2004;106(3):237–240. [published Online First: 2004/06/05]
   PubMed Web of Science ®Google Scholar
• Goldenberg PC, Steiner RD, Merkens LS, et al. Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency. Neurology. 2003;60(5):865–868. [published Online First: 2003/03/12]
   PubMed Web of Science ®Google Scholar
• McKelvie P, Infeld B, Marotta R, et al. Late-adult onset Leigh syndrome. J Clin Neurosci. 2012;19(2):195–202. [published Online First: 2012/01/26]
   PubMed Web of Science ®Google Scholar
• Nagashima T, Mori M, Katayama K, et al. Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol. 1999;97(4):416–422. [published Online First: 1999/04/20]
   PubMed Web of Science ®Google Scholar
• Ostergaard E, Hansen FJ, Sorensen N, et al. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain. 2007;130(Pt 3):853–861. [published Online First: 2007/02/09]
   PubMed Web of Science ®Google Scholar
• Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):257–265. [published Online First: 2013/06/19]
   PubMed Web of Science ®Google Scholar
• Wei Y, Cui L, Peng B. Mitochondrial DNA mutations in late-onset Leigh syndrome. J Neurol. 2018;265(10):2388–2395. [published Online First: 2018/08/22].
   PubMed Web of Science ®Google Scholar
• Sofou K, De Coo IF, Isohanni P, et al. A multicenter study on Leigh syndrome: disease course and predictors of survival. Orphanet J Rare Dis. 2014;9(1):52. [published Online First: 2014/04/16]
   PubMed Web of Science ®Google Scholar
• Malfatti E, Bugiani M, Invernizzi F, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain. 2007;130(Pt 7):1894–1904. [published Online First: 2007/05/31]
   PubMed Web of Science ®Google Scholar
• Rahman S, Blok RB, Dahl HH, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996;39(3):343–351. [published Online First: 1996/03/01]
   PubMed Web of Science ®Google Scholar
• Mayorov VI, Lowrey AJ, Biousse V, et al. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy. BMC Biochem. 2008;9(1):22. [published Online First: 2008/09/12]
   PubMedGoogle Scholar
• Le Roux B, Lenaers G, Zanlonghi X, et al. OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database. Orphanet J Rare Dis. 2019;14(1):214. [published Online First: 2019/09/11]
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133(Pt 3):771–786. [published Online First: 2010/02/17]
   PubMed Web of Science ®Google Scholar
• Verny C, Loiseau D, Scherer C, et al. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology. 2008;70(13 Pt 2):1152–1153. [published Online First: 2008/02/22]
   PubMed Web of Science ®Google Scholar
• Pretegiani E, Rufa A, Gallus GN, et al. Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation. Brain. 2011;134(Pt 11):e195. [published Online First: 2011/06/08]
   PubMed Web of Science ®Google Scholar
• Payne M, Yang Z, Katz BJ, et al. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol. 2004;138(5):749–755. [published Online First: 2004/11/09]
   PubMed Web of Science ®Google Scholar
• Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2008;131(Pt 2):329–337. [published Online First: 2007/12/11]
   PubMed Web of Science ®Google Scholar
• Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain. 2008;131(Pt 2):338–351. [published Online First: 2007/12/26]
   PubMed Web of Science ®Google Scholar
• Toomes C, Marchbank NJ, Mackey DA, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001;10(13):1369–1378. [published Online First: 2001/07/07]
   PubMed Web of Science ®Google Scholar
• Huang T, Santarelli R, Starr A. Mutation of OPA1 gene causes deafness by affecting function of auditory nerve terminals. Brain Res. 2009;1300:97–104. [published Online First: 2009/09/08].
   PubMed Web of Science ®Google Scholar
• Napolitano F, Terracciano C, Bruno G, et al. Intrafamilial “DOA-plus” phenotype variability related to different OMI/HTRA2 expression. Am J Med Genet A. 2020;182(1):176–182. [published Online First: 2019/10/15]
   PubMed Web of Science ®Google Scholar
• Nie S, Chen G, Cao X, et al. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;9(1):179. [published Online First: 2014/11/27]
   PubMed Web of Science ®Google Scholar
• Stelten BML, Van De Warrenburg BPC, Wevers RA, et al. Movement disorders in cerebrotendinous xanthomatosis. Parkinsonism Relat Disord. 2019;58:12–16. [published Online First: 2018/07/29]
   PubMed Web of Science ®Google Scholar
• Pedroso JL, Pinto WB, Souza PV, et al. Early-onset epilepsy as the main neurological manifestation of cerebrotendinous xanthomatosis. Epilepsy Behav. 2012;24(3):380–381. [published Online First: 2012/06/05]
   PubMed Web of Science ®Google Scholar
• Verrips A, Hoefsloot LH, Steenbergen GC, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain. 2000;123(Pt 5):908–919. [published Online First: 2000/04/25]
   PubMed Web of Science ®Google Scholar
• Verrips A, van Engelen BG, Wevers RA, et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol. 2000;57(4):520–524. [published Online First: 2000/04/18]
   PubMedGoogle Scholar
• Mignarri A, Gallus GN, Dotti MT, et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014;37(3):421–429. [published Online First: 2014/01/21]
   PubMed Web of Science ®Google Scholar
• Weingartner O, Laufs U, Bohm M, et al. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis. 2010;209(1):39–41. [published Online First: 2009/10/06]
   PubMed Web of Science ®Google Scholar
• Martini G, Mignarri A, Ruvio M, et al. Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int. 2013;92(3):282–286. [published Online First: 2012/12/06]
   PubMed Web of Science ®Google Scholar
• Kawabata M, Kuriyama M, Mori S, et al. Pulmonary manifestations in cerebrotendinous xanthomatosis. Intern Med. 1998;37(11):922–926. [published Online First: 1998/12/30]
   PubMed Web of Science ®Google Scholar
• Bartholdi D, Zumsteg D, Verrips A, et al. Spinal phenotype of cerebrotendinous xanthomatosis--a pitfall in the diagnosis of multiple sclerosis. J Neurol. 2004;251(1):105–107. [published Online First: 2004/03/05]
   PubMed Web of Science ®Google Scholar
• Verrips A, Nijeholt GJ, Barkhof F, et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain. 1999;122(Pt 8):1589–1595. [published Online First: 1999/08/04]
   PubMed Web of Science ®Google Scholar
• Gelzo M, Di Taranto MD, Bisecco A, et al. A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene. Acta Neurol Belg. 2019;121(2):561–566. [published Online First: 2019/12/26]
   PubMed Web of Science ®Google Scholar
• Chang CC, Lui CC, Wang JJ, et al. Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations. BMC Neurol. 2010;10(1):59. [published Online First: 2010/07/07]
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu W, Jiang B, et al. Fluoxetine-responsive depression in a Chinese cerebrotendinous xanthomatosis. Gen Hosp Psychiatry. 2012;34(5):578e1–4. [published Online First: 2011/12/03]
   Google Scholar
• Pudhiavan A, Agrawal A, Chaudhari S, et al. Cerebrotendinous xanthomatosis--the spectrum of imaging findings. J Radiol Case Rep. 2013;7(4):1–9. [published Online First: 2013/05/25]
   PubMedGoogle Scholar
• Yunisova G, Tufekcioglu Z, Dogu O, et al. Patients with lately diagnosed cerebrotendinous xanthomatosis. Neurodegener Dis. 2019;19(5–6):218–224. [published Online First: 2020/04/30]
   PubMed Web of Science ®Google Scholar
• Lin TK, Chang YY, Lin HY, et al. Mitochondrial dysfunctions in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). PLoS One. 2019;14(10):e0224173. [published Online First: 2019/11/02]
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, van der Voorn P, Barkhof F, et al. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol. 2003;53(2):252–258. [published Online First: 2003/01/31]
   PubMed Web of Science ®Google Scholar
• Steenweg ME, van Berge L, van Berkel CG, et al. Early-onset LBSL: how severe does it get? Neuropediatrics. 2012;43(6):332–338. [published Online First: 2012/10/16]
   PubMed Web of Science ®Google Scholar
• Martikainen MH, Ellfolk U, Majamaa K. Impaired information-processing speed and working memory in leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate (LBSL) and DARS2 mutations: a report of three adult patients. J Neurol. 2013;260(8):2078–2083. [published Online First: 2013/05/09].
   PubMed Web of Science ®Google Scholar
• Galluzzi P, Sacchini M, Bartalini G, et al. LBSL (leukoencephalopathy with brain stem and spinal cord involvement and high lactate) without sparing of the u-fibers and globi pallidi: a case report. Eur J Radiol Extra. 2011;79(2):e73–e76.
   Google Scholar
• Kassem H, Wafaie A, Abdelfattah S, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL): assessment of the involved white matter tracts by MRI. Eur J Radiol. 2014;83(1):191–196. [published Online First: 2014/02/22]
   PubMed Web of Science ®Google Scholar
• Hahn JS, Pohl D, Rensel M, et al. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology. 2007;68(16 Suppl 2):S13–22. [published Online First: 2007/04/18]
   PubMed Web of Science ®Google Scholar
• Isohanni P, Linnankivi T, Buzkova J, et al. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. J Med Genet. 2010;47(1):66–70. [published Online First: 2009/07/14]
   PubMed Web of Science ®Google Scholar
• Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165–1176. [published Online First: 2015/07/15].
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Hudson G, et al. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46(3):145–158. [published Online First: 2008/11/13]
   PubMed Web of Science ®Google Scholar
• Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140(3):517–523. [published Online First: 2005/08/09].
   PubMed Web of Science ®Google Scholar
• Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53–89. [published Online First: 2004/02/10].
   PubMed Web of Science ®Google Scholar
• Martikainen MH, Ng YS, Gorman GS, et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol. 2016;73(6):668–674. [published Online First: 2016/04/26]
   PubMed Web of Science ®Google Scholar
• Pfeffer G, Burke A, Yu-Wai-Man P, et al. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology. 2013;81(24):2073–2081. [published Online First: 2013/11/08]
   PubMed Web of Science ®Google Scholar
• Palace J. Multiple sclerosis associated with Leber’s hereditary optic neuropathy. J Neurol Sci. 2009;286(1–2):24–27. [published Online First: 2009/10/06].
   PubMed Web of Science ®Google Scholar
• Matthews L, Enzinger C, Fazekas F, et al. MRI in Leber’s hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(5):537–542. [published Online First: 2014/07/24]
   PubMed Web of Science ®Google Scholar
• Rosciszewska-Zukowska I, Bartosik-Psujek H. Optic nerve atrophy and whole and regional brain atrophy in Leber’s hereditary optic neuropathy with multiple sclerosis-like disease with m.11778G>A mutation. Mult Scler Relat Disord. 2020;42:102071. [published Online First: 2020/05/11].
   PubMed Web of Science ®Google Scholar
• Blanc C, Heran F, Habas C, et al. MRI of the Optic nerves and chiasm in patients with leber hereditary optic neuropathy. J Neuroophthalmol. 2018;38(4):434–437. [published Online First: 2018/01/05]
   PubMed Web of Science ®Google Scholar
• Horvath R, Abicht A, Shoubridge EA, et al. Leber’s hereditary optic neuropathy presenting as multiple sclerosis-like disease of the CNS. J Neurol. 2000;247(1):65–67. [published Online First: 2000/03/04]
   PubMed Web of Science ®Google Scholar
• Bargiela D, Chinnery PF. Mitochondria in neuroinflammation - Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett. 2019;710:132932. [published Online First: 2017/07/03].
   PubMed Web of Science ®Google Scholar
• Jurkute N, Harvey J, Yu-Wai-Man P. Treatment strategies for Leber hereditary optic neuropathy. Curr Opin Neurol. 2019;32(1):99–104. [published Online First: 2018/12/06].
   PubMed Web of Science ®Google Scholar